Businesses in the industry are always concentrating on tactics like joint ventures and the The market for Esoteric Testing Market is expected to increase rapidly worldwide. Although Esoteric Testing Market have made great strides, one of the main obstacles to their clinical application is the laborious process of converting them into practical clinical assays. This market is expected to rise due to reasons like rising healthcare costs, more funding for research and development, the growing use of biomarkers for diagnostic purposes, and an increase in Esoteric Testing Market research.
The scale of the Esoteric Testing Market was verified, and the sizes of several other dependent submarkets were estimated, using both top-down and bottom-up methods. Secondary research was used to identify the market’s major participants, and primary and secondary research was used to calculate their market revenues. While primary research involved in-depth interviews with important opinion leaders like CEOs, directors, and marketing executives, secondary research involved examining the annual and financial reports of major market competitors. Primary sources were used to verify the segment % splits, shares, and breakdowns that were calculated from secondary sources. This report presents the combined data together with in-depth inputs and analysis from us.
Research Methodology:
After secondary research provided a fundamental understanding of the worldwide Esoteric Testing Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering Esoteric Testing Market details, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered.
Esoteric Testing Market based on Test Type:
- Endocrinology
- Infectious Disease
- Oncology
- Neurology
- Toxicology
- Others
Esoteric Testing Market based on Technology:
- Flow Cytometry
- Chemiluminescence Immunoassay
- Mass Spectrometry
- Radio Immunoassay
- Others
Esoteric Testing Market based on Geography:
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Esoteric testing is a low-cost, high-throughput technique that effectively detects many tumor markers. It is also easy to operate. Certain in-vitro methods can be used to measure cancer-specific antibody levels under esoteric assays.
The growing significance of early cancer diagnosis and treatment is likely to fuel the oncology segment’s robust expansion in the esoteric testing market over the forecast period. One of the occult tests used to evaluate stool samples for hidden (occult) blood is the fecal occult blood test (FOBT). Blood in the stool could be a sign of polyps in the colon or the rectum, or it could be colon cancer.
In addition, the number of cancer cases has raised the need for esoteric testing to diagnose illnesses. For example, the FICCI-EY Paper estimates that 19 to 20 lakh new cases of cancer will be reported in India in 2022. The real incidence of cancer is estimated to be 1.5–3 times higher than the data provided by cancer registries. As a result, during the course of the forecast period, there is anticipated to be a notable increase in esoteric tests that aid in the diagnosis of colon cancer, such as fecal occult blood tests.
Additionally, it is anticipated that the demand for testing will be driven by the rising spending in R&D activities. The total R&D spending for the pharmaceutical business in the European region in 2020 was estimated by the EFPIA to be around EUR 39,656 million (USD 411,31.20 million) and EUR 41,500 million (USD 43,043.80 million) in 2021. This indicates a rise in research R&D spending, which should encourage the creation of more advanced esoteric testing.
Due to the rise in R&D expenditures and activities, the burden of chronic diseases, and the number of uncommon disease cases, North America is anticipated to hold a leading position in the esoteric testing market. According to NORD data, there were around 25–30 million individuals with rare diseases in 2021. Furthermore, about ten percent of Americans suffer from an uncommon illness, with children making up the majority of these cases. Furthermore, by the end of 2022, the NIH RCDC projects that funding for research on rare diseases in the US will have increased to USD 6,482 million from USD 6,191 million in 2021.
The launch of new testing services and partnerships between significant regional companies help propel the market’s expansion. For example, in January 2021, Scarlet Health—an in-home, fully integrated digital platform that offers access to on-demand diagnostic services—was developed by BioReference Laboratories, Inc., an OPKO Health subsidiary. Scarlet’s design is intuitive and widely convenient, akin to the everyday instruments used by consumers. Similar to this, in February 2021, Quest Diagnostics and GRAIL, Inc. reached an agreement for phlebotomy services to support Galleri, GRAIL’s multi-cancer early detection blood test.
Similarly, in 2020, LabCorp received an EUA from the US FDA to use their COVID-19 RT-PCR Test to check for coronavirus illness in patient-collected nasal swab samples. The testing was carried out at LabCorp’s Center for Esoteric Testing and other high-complexity facilities the business developed that were certified under the Clinical Laboratory Improvement Amendments (CLIA), even though the EUA allows sample collection at home. It is anticipated that each of these elements will support the nation’s esoteric testing market’s expansion.
- This report illustrates the most vital attributes of the Esoteric Testing Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the Esoteric Testing Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the Esoteric Testing Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Esoteric Testing Market.
Methodology
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
- Forecasting
List of Tables
TABLE 1. ESOTERIC TESTING MARKET VALUE, BY TEST TYPE, 2021-2030 (USD BILLION)
TABLE 2. ESOTERIC TESTING MARKET VALUE FOR ENDOCRINOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 3. ESOTERIC TESTING MARKET VALUE FOR INFECTIOUS DISEASE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. ESOTERIC TESTING MARKET VALUE FOR ONCOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. ESOTERIC TESTING MARKET VALUE FOR TOXICOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. ESOTERIC TESTING MARKET VALUE, BY TECHNOLOGY, 2021-2030 (USD BILLION)
TABLE 7. ESOTERIC TESTING MARKET VALUE FOR FLOW CYTOMETRY, 2021-2030 (USD BILLION)
TABLE 8. ESOTERIC TESTING MARKET VALUE FOR CHEMILUMINESCENCE IMMUNOASSAY, 2021-2030 (USD BILLION)
TABLE 9. ESOTERIC TESTING MARKET VALUE FOR MASS SPECTROMETRY, 2021-2030 (USD BILLION)
TABLE 10. ESOTERIC TESTING MARKET VALUE FOR RADIO IMMUNOASSAY, 2021-2030 (USD BILLION)
TABLE 11. NORTH AMERICA ESOTERIC TESTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 12. NORTH AMERICA ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 14. U.S ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 15. U.S ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 16. CANADA ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 17. CANADA ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 18. MEXICO ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 19. MEXICO ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 20. EUROPE ESOTERIC TESTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 21. EUROPE ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 22. EUROPE ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 23. GERMANY ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 24. GERMANY ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 25. U.K ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 26. U.K ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 27. FRANCE ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 28. FRANCE ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 29. ITALY ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 30. ITALY ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 31. SPAIN ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 32. SPAIN ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 33. ROE ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 34. ROE ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 35. ASIA PACIFIC ESOTERIC TESTING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 36. ASIA PACIFIC ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 37. ASIA PACIFIC ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 38. CHINA ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. CHINA ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 40. INDIA ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 41. INDIA ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 42. JAPAN ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 43. JAPAN ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 44. REST OF APAC ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. REST OF APAC ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 46. LATIN AMERICA ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 47. LATIN AMERICA ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 48. BRAZIL ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 49. BRAZIL ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 50. ARGENTINA ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 51. ARGENTINA ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 52. MIDDLE EAST AND AFRICA ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 53. MIDDLE EAST AND AFRICA ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 54. SAUDI ARABIA ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 55. SAUDI ARABIA ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 56. UAE ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 57. UAE ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 58. REST OF MIDDLE EAST AND AFRICA ESOTERIC TESTING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 59. REST OF MIDDLE EAST AND AFRICA ESOTERIC TESTING MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 60. ACM GLOBAL LABORATORIES (US): FINANCIALS
TABLE 61. ACM GLOBAL LABORATORIES (US): PRODUCTS & SERVICES
TABLE 62. ACM GLOBAL LABORATORIES (US): RECENT DEVELOPMENTS
TABLE 63. ARUP LABORATORIES (US) : FINANCIALS
TABLE 64. ARUP LABORATORIES (US) : PRODUCTS & SERVICES
TABLE 65. ARUP LABORATORIES (US) : RECENT DEVELOPMENTS
TABLE 66. BAYLOR ESOTERIC AND MOLECULAR LABORATORY (US): FINANCIALS
TABLE 67. BAYLOR ESOTERIC AND MOLECULAR LABORATORY (US): PRODUCTS & SERVICES
TABLE 68. BAYLOR ESOTERIC AND MOLECULAR LABORATORY (US): RECENT DEVELOPMENTS
TABLE 69. BIOAGILYTIX LABS (US): FINANCIALS
TABLE 70. BIOAGILYTIX LABS (US): PRODUCTS & SERVICES
TABLE 71. BIOAGILYTIX LABS (US): RECENT DEVELOPMENTS
TABLE 72. BP DIAGNOSTIC CENTRE SDN BHD (MALAYSIA): FINANCIALS
TABLE 73. BP DIAGNOSTIC CENTRE SDN BHD (MALAYSIA): PRODUCTS & SERVICES
TABLE 74. BP DIAGNOSTIC CENTRE SDN BHD (MALAYSIA): RECENT DEVELOPMENTS
TABLE 75. BUHLMANN DIAGNOSTICS CORP (BDC, US): FINANCIALS
TABLE 76. BUHLMANN DIAGNOSTICS CORP (BDC, US): PRODUCTS & SERVICES
TABLE 77. BUHLMANN DIAGNOSTICS CORP (BDC, US): RECENT DEVELOPMENTS
TABLE 78. CERBA XPERT (BELGIUM): FINANCIALS
TABLE 79. CERBA XPERT (BELGIUM): PRODUCTS & SERVICES
TABLE 80. CERBA XPERT (BELGIUM): DEVELOPMENTS
TABLE 81. EUROFINS SCIENTIFIC (LUXEMBOURG): FINANCIALS
TABLE 82. EUROFINS SCIENTIFIC (LUXEMBOURG): PRODUCTS & SERVICES
TABLE 83. EUROFINS SCIENTIFIC (LUXEMBOURG): RECENT DEVELOPMENTS
TABLE 84. FLOW HEALTH (US): FINANCIALS
TABLE 85. FLOW HEALTH (US): PRODUCTS & SERVICES
TABLE 86. FLOW HEALTH (US): RECENT DEVELOPMENTS
TABLE 87. FOUNDATION MEDICINE (US): FINANCIALS
TABLE 88. FOUNDATION MEDICINE (US): PRODUCTS & SERVICES
TABLE 89. FOUNDATION MEDICINE (US): RECENT DEVELOPMENTS
